Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Backer

Showing results (341-350 of 370) with videos related to

Pageof 37
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 28, 2025
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE TrialCeleste Porsbjerg, Eleanor M Dunican, Njira L Lugogo, et al.
Respiratory Medicine|June 7, 2026
Infertility in women with asthma - does asthma also exist in the uterus?Anne Vejen Hansen, Casper Tidemandsen, Henriette Svarre Nielsen, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
European Clinical Respiratory Journal|April 15, 2020
Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPDVibeke Backer, Ditte K Klein, Uffe Bodtger, et al.
The European Respiratory Journal|November 6, 2025
Mortality in Severe Asthma - results from the NORDSTAR cohortSusanne Hansen, Anna von Bülow, Alexandra Cooper, et al.
Frontiers in Allergy|June 30, 2022
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
The New England Journal of Medicine|July 3, 2009
Preoperative staging of lung cancer with combined PET-CTBarbara Fischer, Ulrik Lassen, Jann Mortensen, et al.
Frontiers in Allergy|January 29, 2026
Global airways: a Danish nationwide real-life registry of biologic therapy for chronic rhinosinusitis with nasal polypsVibeke Backer, Kasper Aanæs, Bent Ivan Larsen, et al.
Frontiers in Allergy|October 29, 2025
Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registryVibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, et al.
Frontiers in Allergy|September 26, 2022
Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
Pageof 37

Showing results (341-350 of 370) with videos related to

Sort By:
Pageof 37
American Journal of Respiratory and Critical Care Medicine|October 28, 2025
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE TrialCeleste Porsbjerg, Eleanor M Dunican, Njira L Lugogo, et al.
Respiratory Medicine|June 7, 2026
Infertility in women with asthma - does asthma also exist in the uterus?Anne Vejen Hansen, Casper Tidemandsen, Henriette Svarre Nielsen, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
European Clinical Respiratory Journal|April 15, 2020
Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPDVibeke Backer, Ditte K Klein, Uffe Bodtger, et al.
The European Respiratory Journal|November 6, 2025
Mortality in Severe Asthma - results from the NORDSTAR cohortSusanne Hansen, Anna von Bülow, Alexandra Cooper, et al.
Frontiers in Allergy|June 30, 2022
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
The New England Journal of Medicine|July 3, 2009
Preoperative staging of lung cancer with combined PET-CTBarbara Fischer, Ulrik Lassen, Jann Mortensen, et al.
Frontiers in Allergy|January 29, 2026
Global airways: a Danish nationwide real-life registry of biologic therapy for chronic rhinosinusitis with nasal polypsVibeke Backer, Kasper Aanæs, Bent Ivan Larsen, et al.
Frontiers in Allergy|October 29, 2025
Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registryVibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, et al.
Frontiers in Allergy|September 26, 2022
Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
Pageof 37